Publications

69. LaForce, C.F., Carr, W., Tilles, S.A., Chipps, B.E., Storms, W., Meltzer, E.O., and Edwards, M. Evaluation of Olopatatadine Hydrochloride Nasal Spray, 0.6%, used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis. Allergy Asthma Proc. 2010; 31:132-140. View

68. Goldsobel, A., Chipps, B.E. Cough in Pediatric Population. Journal of Pediatrics 2010; 156 (3): 352-358. View

67. Benninger, M., Farrar J.R., Blaiss, M., Chipps, B.E., Ferguson, B., Krouse, J.,
Marple, B., Storms, W., and Kaliner, M. Evaluating Approved Medications to Treat Allergic Rhinitis in the United States: An Evidenced-Based Review of Efficacy for Nasal Symptoms by Class. Ann Allergy Asthma Immunol 2010; 104: 13-29. View

66. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, F.E.R.,
and Fish, J.E. Comparison of Asthma Exacerbations in Pediatric and Adult Patients with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 24:1106-1108. View

65. Haselkorn, T., Fish, J.E., Zeiger, R.S., Szefler, S.J., Miller, D.P., Chipps, B.E., Simons, E.R., Weiss, S.T., Wenzel, S.E., Borish, L., and Bleecker, E.R. Consistently Very Poorly Controlled Asthma by the Impairment Domain of the EPR-3 Guidelines Increases Risk for Future Severe Asthma Exacerbations in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study. J Allergy Clin Immunol 2009; 124: 895-902 e.4. View

64. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, E.R., and Fish, J.E. Recent Asthma Exacerbations Predict Future Exacerbations in Children with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 124: 921-927. View

63. Chipps B.E. and Harder J. Antihistamine treatment for allergic rhinitis: Different routes, different outcomes. Allergy Asthma Proc. 2009 November-December;30(6): 589-594. View

***Updated 1/23/2022***

FROM CAPITAL ALLERGY & RESPIRATORY DISEASE CENTER

COVID VACCINE ALERT

Please be aware that we recommend patients do not receive allergy shots of biologics injections for 7 days after receiving a COVID vaccine. This may cause a need to reschedule an injection appointment. Please call our office to change appointment times or for any questions or concerns. You can also contact us through the patient portal.

************************************************

COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.

https://covid19.ca.gov/vaccines/#When-can-I-get-vaccinated

************************************************

Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

View More

New Injection Hours – Effective 1/10/2022

Folsom Office
Monday 8:00-11:30 / 1-4:30
Tuesday Closed
Wednesday 8:00-11:30 / 1-4:30
Thursday 8:00-11:30 / 1-4:30
Friday 8:00-11:30 / 1-4:30

Roseville Office
Monday 9:00-11:30 / 1-5:30
Tuesday 8:00-11:30 / 1-4:30
Wednesday 8:00-11:30 / 1-4:30
Thursday 8:00-11:30 / 1-4:30
Friday 8:00-11:30 / 1-4:30

Sacramento
Monday 9:00-4:30
Tuesday 8:00-5:30
Wednesday 8:00-11:30 / 1-4:30
Thursday 9:00-4:30
Friday 8:00-4:30